Nice post. Good points. But even companies with product and recurring revenue have a lifespan, or a profit margin that eventually degrades into being manufactured for cost at times. The R&D costs as well as the ad and manufacturing costs. It`s the glass half full half empty view for me. Nothing wrong with being between 10-20 times TTM earnings. The street just needs the numbers to adjust the valuation now IMO.